| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AGLE | Aeglea BioTherapeutics, Inc. | Charles N. York II | Chief Financial Officer and VP | Aug 15, 2017 | Buy | $2.52 | 1,959 | 4,929 | 14,787 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Charles N. York II | Chief Financial Officer and VP | Dec 01, 2017 | Buy | $4.59 | 6,500 | 29,855 | 21,287 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Charles N. York II | Chief Financial Officer and VP | Dec 04, 2017 | Buy | $4.97 | 3,259 | 16,197 | 24,546 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Charles N. York II | Chief Financial Officer and VP | Dec 05, 2017 | Buy | $4.76 | 10,241 | 48,700 | 34,787 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Charles N. York II | Chief Financial Officer and VP | Aug 15, 2016 | Buy | $3.99 | 2,000 | 7,974 | 10,828 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Charles N. York II | Chief Financial Officer and VP | Feb 15, 2017 | Buy | $4.28 | 2,000 | 8,568 | 12,828 | Dec 05, 2017, 09:07 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Charles N. York II | Chief Financial Officer and VP | Apr 12, 2016 | Conversion | - | 1,324 | - | 8,828 | Apr 12, 2016, 05:15 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Charles N. York II | Chief Financial Officer and VP | Apr 12, 2016 | Conversion | - | 11,560 | - | 11,560 | Apr 12, 2016, 05:15 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More